An open randomized clinical trial in comparing two artesunate-based combination treatments on <it>Plasmodium falciparum </it>malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours)

<p>Abstract</p> <p>Background</p> <p>Several studies have demonstrated the efficacy of artemisinin-combination therapy (ACT) across malaria zones of the world. Fixed dose ACT with shorter courses and fewer tablets may be key determinants to ease of administration and co...

Full description

Bibliographic Details
Main Authors: Sowunmi Akintunde, Falade Adegoke, Ayede Idowu, Jansen Frans
Format: Article
Language:English
Published: BMC 2010-12-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/9/1/378